THE DEAL, AT A GLANCE
From the announcementRealmind Biotech
01What it doesRealmind Biotech develops Vitro diagnostic devices intended for medical assessments.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by our team of analystsFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedRealmind Biotech raised $7.4M Series C, announced 2026-09-28From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersRealmind Biotech's $7.4M Series C supports a diagnostics company moving production to Huangshan while developing in vitro diagnostic devices for medical assessments.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Realmind Biotech · Financing Record
Explore source-linked visual explanations for Realmind Biotech. Unsupported claims are withheld while source review continues.
Record 12943 · Recorded date: 2026-09-28
Explore company records →